Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:AMAR OTCMKTS:BETRF OTCMKTS:CPMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMARAmarillo Biosciences$0.00$0.05▼$1.97$25.24M-0.0618,253 shs6,100 shsBETRFBetterLife Pharma$0.05+0.2%$0.05$0.03▼$0.09$7.70M0.5435,557 shs27,215 shsCPMDGolden Dragon$0.00$0.00$0.00▼$0.01$2.50M2.2235,416 shs1,500 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMARAmarillo Biosciences0.00%0.00%0.00%0.00%0.00%BETRFBetterLife Pharma+5.79%+1.28%-8.65%+23.70%-29.63%CPMDGolden Dragon0.00%0.00%-5.13%+2.78%+12.12%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMARAmarillo Biosciences$0.00$0.05▼$1.97$25.24M-0.0618,253 shs6,100 shsBETRFBetterLife Pharma$0.05+0.2%$0.05$0.03▼$0.09$7.70M0.5435,557 shs27,215 shsCPMDGolden Dragon$0.00$0.00$0.00▼$0.01$2.50M2.2235,416 shs1,500 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMARAmarillo Biosciences0.00%0.00%0.00%0.00%0.00%BETRFBetterLife Pharma+5.79%+1.28%-8.65%+23.70%-29.63%CPMDGolden Dragon0.00%0.00%-5.13%+2.78%+12.12%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMARAmarillo Biosciences 0.00N/AN/AN/ABETRFBetterLife Pharma 0.00N/AN/AN/ACPMDGolden Dragon 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMARAmarillo Biosciences$20K0.00N/AN/A($0.03) per share0.00BETRFBetterLife PharmaN/AN/AN/AN/A($0.04) per shareN/ACPMDGolden Dragon$1.36M1.84N/AN/A($0.05) per share-0.07Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMARAmarillo Biosciences-$1.45MN/AN/AN/AN/A-41,453.98%N/A-574.29%N/ABETRFBetterLife Pharma-$2.55MN/AN/AN/AN/AN/AN/A-764.44%5/27/2026 (Estimated)CPMDGolden Dragon-$11.13M-$0.01N/AN/AN/A-816.80%N/A-107.71%N/ALatest AMAR, CPMD, and BETRF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/31/2026Q4 2025CPMDGolden DragonN/A-$0.01N/A-$0.01N/A$0.14 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAMARAmarillo BiosciencesN/AN/AN/AN/AN/ABETRFBetterLife PharmaN/AN/AN/AN/AN/ACPMDGolden DragonN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMARAmarillo BiosciencesN/A0.030.07BETRFBetterLife PharmaN/A0.050.05CPMDGolden DragonN/A0.040.01Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMARAmarillo BiosciencesN/ABETRFBetterLife Pharma0.01%CPMDGolden DragonN/AInsider OwnershipCompanyInsider OwnershipAMARAmarillo Biosciences34.35%BETRFBetterLife Pharma34.77%CPMDGolden Dragon1.27%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMARAmarillo Biosciences242.07 millionN/ANot OptionableBETRFBetterLife Pharma7161.79 million105.53 millionNot OptionableCPMDGolden Dragon4676.63 million668.03 millionNot OptionableAMAR, CPMD, and BETRF HeadlinesRecent News About These CompaniesCannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026January 12, 2026 | accessnewswire.comACrimson Desert: How the Golden Star Dragon Boss Was CreatedOctober 17, 2025 | msn.comWeRide adds to its visibility with inclusion on the Nasdaq Golden Dragon China IndexSeptember 23, 2025 | msn.comCannaPharmaRX Expands Cannabis Exports, Projects $1M+ Q3 RevenueAugust 19, 2025 | accessnewswire.comACannapharmaRx Continues into New European Market with First Shipment Completed to GermanyMay 6, 2025 | accessnewswire.comACannapharmaRX Updates on Alberta Facility Progress and International Export StrategyDecember 4, 2024 | finance.yahoo.comCannapharmaRx to Complete Additional Shipment in NovemberNovember 5, 2024 | accesswire.comAPSIQ Profile Solutions, Inc.August 16, 2024 | seekingalpha.comCannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of ProductAugust 15, 2024 | accesswire.comAQ1 2024 Financial ResultsJune 28, 2024 | accesswire.comACannaPharmaRX, Inc. (CPMD)May 22, 2024 | finance.yahoo.comCannaPharmaRx to Host Investor Conference CallMay 20, 2024 | finance.yahoo.comCORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference CallMay 20, 2024 | finance.yahoo.comCannapharmaRx Pays Off Convertible NotesApril 2, 2024 | accesswire.comACannapharmarx, Inc.: CannapharmaRx Receives First Purchase Order and Begins Shipment of ProductMarch 14, 2024 | finanznachrichten.deCannapharmaRx Receives First Purchase Order and Begins Shipment of ProductMarch 14, 2024 | accesswire.comACannaPharmaRx, Inc.: CannaPharmaRx Completes First HarvestsMarch 12, 2024 | finanznachrichten.deCannaPharmaRx Completes First HarvestsMarch 12, 2024 | accesswire.comACannapharmarx, Inc.: CannaPharmaRx to Hold Investor Conference CallMarch 7, 2024 | finanznachrichten.deCannaPharmaRx to Hold Investor Conference CallMarch 7, 2024 | accesswire.comAMedia Sentiment Over TimeAMAR, CPMD, and BETRF Company DescriptionsAmarillo Biosciences OTCMKTS:AMARAmarillo Biosciences, Inc., a healthcare company, engages in the discovery and development of pharmaceutical and biotech products in the United States and Asia. The company operates in three divisions: Pharmaceutical, Medical, and Consumer. The Pharmaceutical division offers low-dose non-injectable interferon (IFN) for the treatment of neoplastic, viral, and fibrotic diseases. The Medical division focuses on medical devices and developing technology to treat metabolism related diseases, such as Type 1 and Type 2 diabetes. The Consumer division provides a range of nutraceutical and food supplement products that utilize a liposomal delivery system. It owns four issued patents related to the low-dose oral delivery of interferon; one patent is for a product promoting oral health; and three patents are associated with treatment of metabolic disorders. The company was incorporated in 1984 and is based in Amarillo, Texas.BetterLife Pharma OTCMKTS:BETRF$0.05 +0.00 (+0.21%) As of 11:13 AM EasternBetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benzodiazepine dependency, anxiety, and neurodegenerative disorders. It is also developing MM-003, which has completed Phase II clinical trials for treatment of COVID-19 and other respiratory viral infections; and MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia that has completed Phase II clinical trials. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.Golden Dragon OTCMKTS:CPMD$0.0037 0.00 (0.00%) As of 10:45 AM EasternCannaPharmaRX, Inc. operates in the cannabis industry in Canada. It evaluates, negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Vertical Aerospace: Pre-Flight Checks Point to a Breakout HIVE Weaponizes Power for an AI Pivot Strategy Inc. Buys Bitcoin and Eyes a Dividend Amid Market Fear Arhaus Stock Drops to 52-Week Low After Q1 Earnings Tesla Ends Model S and X Era, Bets Everything on What's Next Why Home Depot’s Sell-Off Could Become a Huge Opportunity Palo Alto Networks Up 70%: Can the Rally Last Into June? Brady Corp Wires Up a Massive AI-Powered Breakout Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
